A Study of AL102 in Patients With Progressing Desmoid Tumors
Trial ID or NCT#
Status
Purpose
The current study is designed to evaluate the efficacy and safety of AL102 in patients with progressive desmoid tumors.
Official Title
RINGSIDE: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients With Progressing Desmoid Tumors
Eligibility Criteria
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Ileana Aguilar Torres
ileanaa@stanford.edu
View on ClinicalTrials.gov